JW Lifescience Corporation
KSC: 234080.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Sungnam Cha
- Employees
- 301
- Headquarters
- Dangjin-si, South Korea
- IPO year
- 2016
- Market cap
- ₩199.4B
- Website
- https://www.jw-lifescience.co.kr
Loading 234080…
Loading profile data…Frequently asked questions about 234080
What does JW Lifescience Corporation (234080.KS) do?
JW Lifescience Corporation engages in the development, production, and sale of infusion solutions in South Korea and internationally. It offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special i...
Where does 234080.KS trade?
JW Lifescience Corporation (234080.KS) trades on the Korea Exchange.
What sector is 234080.KS in?
JW Lifescience Corporation (234080.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of JW Lifescience Corporation?
Sungnam Cha is the chief executive officer of JW Lifescience Corporation (234080.KS).
Where is JW Lifescience Corporation headquartered?
JW Lifescience Corporation is headquartered in South Korea.
Does 234080.KS pay a dividend?
Yes — JW Lifescience Corporation (234080.KS) paid a trailing twelve-month dividend of KRW 550.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 234080.KS go public?
JW Lifescience Corporation (234080.KS) completed its initial public offering in 2016.